Levonorgestrel-releasing intrauterine system: why do some women dislike it?

References

• Hurskainen R, Paavonen J. Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 2004; 16: 487–490
   PubMed Web of Science ®Google Scholar
• Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. Bjog 2000; 107: 335–339
   PubMed Web of Science ®Google Scholar
• Halmesmaki K, Hurskainen R, Teperi J, Grenman S, Kivela A, Kujansuu E, Tuppurainen M, Yliskoski M, Vuorma S, Paavonen J. The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial. Bjog 2007; 114: 563–568
   PubMed Web of Science ®Google Scholar
• National-Institute-for-Health-and-Clinical-Excellence. Long-acting reversible contraception. NICE Clinical Guidelines 30. RCOG, London 2005
   Google Scholar
• Lockhat F B, Emembolu J E, Konje J C. Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel. Fertil Steril 2005; 83: 398–404
   PubMed Web of Science ®Google Scholar
• Raudaskoski T, Tapanainen J, Tomas E, Luotola H, Pekonen F, Ronni-Sivula H, et al. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response. Bjog 2002; 109: 136–144
   PubMed Web of Science ®Google Scholar
• Lockhat F B, Emembolu J O, Konje J C. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum Reprod 2005; 20: 789–793
   PubMed Web of Science ®Google Scholar
• Hurskainen R, Teperi J, Rissanen P, Aalto A M, Grenman S, Kivela A, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004; 291: 1456–1463
   PubMed Web of Science ®Google Scholar
• Lewis P, Selvakumari N K, Neelapalla P. The levonorgestrel-releasing intrauterine system for menorrhagia. Br J Hosp Med (Lond) 2006; 67: 46
   PubMed Web of Science ®Google Scholar
• Nagrani R, Bowen-Simpkins P, Barrington J W. Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia. Bjog 2002; 109: 345–347
   PubMed Web of Science ®Google Scholar
• Cox M, Tripp J, Blacksell S. Clinical performance of levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5 year report. J Family Planning Reprod Health Care 2002; 28: 73–77
   PubMed Web of Science ®Google Scholar
• Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994; 49: 56–72
   PubMed Web of Science ®Google Scholar
• Crosignani P G, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997; 90: 257–263
   PubMed Web of Science ®Google Scholar
• Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR). Fertil Steril 1994; 61: 70–77
   PubMed Web of Science ®Google Scholar
• Backman T, Huhtala S, Luoto R, Tuominen J, Rauramo I, Koskenvuo M. Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstet Gynecol 2002; 99: 608–613
   PubMed Web of Science ®Google Scholar
• Macnab J L, Lowles I E. Levonorgestrel-releasing intrauterine system for menstrual dysfunction: patient satisfaction in the district general hospital setting. J Obstet Gynaecol 2002; 22: 402–405
   PubMedGoogle Scholar
• Andersson J K, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990; 97: 690–694
   PubMedGoogle Scholar
• Ewies A A. Mirena: the other side of the story. Bjog 2007; 114: 1307–1308
   PubMed Web of Science ®Google Scholar
• World-Health-Organization-(WHO). Medical eligibility criteria for contraceptive use. WHO, Geneva, Switzerland 2000
   Google Scholar
• Bayer-plc. Electronic Medicines Compendium: Norgeston, 2001, Available at http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?DocumentID=1834#PHARMACOKINETIC_PROPS via the INTERNET. Accessed 2007 December 24
   Google Scholar
• Wahab M, Al-Azzawi F. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders. Bjog 2005; 112: 1455–1456
   PubMed Web of Science ®Google Scholar